Tag: team

NEW YORK, July 03, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Rocket Pharmaceuticals, Inc. ("Rocket" or the "Company") (NASDAQ: RCKT) of a class action securities lawsuit.

Singapore, July 03, 2025 (GLOBE NEWSWIRE) -- The UPCX innovative open-source blockchain payment platform has announced a new staking event, offering a total reward pool of up to 10,000 UPC (approximately $38,000). The event will run fromJuly 1, 2025, to July 31, 2025, aiming to reward community supporters while promoting the continued development and long-term goals of the UPCX ecosystem.

 

UPCX leverages highly optimized blockchain technology, focusing on fast transactions, high security, and cross-chain interoperability to provide a seamless and convenient payment experience for users, merchants, and institutions. Its governance token,UPC, has been successfully listed on Japan’s compliant exchange BitTrade, as well as prominent platforms such as MEXC, Bitget, Gate.io, WEEX, and Websea.

How to Participate in the UPCX Staking Event

Event Period: July 1, 2025 – July 31, 2025

Official Staking Platform:https://upcx-staking.io/

Reward Claim Form:https://forms.gle/SYs8TwS8jVThEVcf7

Participation Steps

1. Visit the Official Staking PlatformGo to the UPCX official staking platform and connect your wallet.
2. Select Staking Amount and Lockup PeriodEnter the amount of UPC you wish to stake.   Available lockup periods:30 days,90 days, or180 days. Longer lockup periods offer higher reward coefficients.
3. Complete Authorization and Staking

First, complete the[Approve]authorization.
Then, click[Stake Now]to stake and confirm the transaction.
Gas fees incurred during authorization and staking will be reimbursed in equivalent $UPC to your staking wallet address after the event ends.

4. Submit Reward Claim InformationAfter staking, fill out the official reward claim form with your staking details and wallet address to ensure smooth reward distribution.
5. Await Reward DistributionAfter the event concludes, rewards will be distributed to your staking wallet based on the staked amount and lockup period.

The UPCX team reserves the right to the final interpretation of the event. For any questions, please contact official customer support or join the official community for assistance.

Reward Rules

1. Standard Reward Pool

Stake >10 UPC: Share1,500 UPC

Stake >500 UPC: Share2,500 UPC

Stake >1,000 UPC: Share4,000 UPC

2. Long-Term Lockup Bonus Pool

Stake ≥25 UPC, lock for 90 days: Share400 UPC

Stake ≥25 UPC, lock for 180 days: Share600 UPC

More about UPCX:

UPCX is a blockchain-based open-source payment platform that aims to provide secure, transparent, and compliant financial services to global users. It supports fast payments, smart contracts, cross-asset transactions, user-issued assets (UIA), non-fungible tokens (NFA), and stablecoins. Moreover, it offers a decentralized exchange (DEX), APIs, and SDKs, allows customized payment solutions, and integrates POS applications and hardware wallets for enhanced security, building a one-stop financial ecosystem.

UPCX Whitepaper 1.0
https://upcx.io/zh-CN/whitepaper/

UPCX Linktree
https://link3.to/upcx

NFM Lending and the NFM Family of Lenders are proud to announce that LaTasha Waddy, Executive Vice President and Chief Legal Officer, has been named one of HousingWire’s 2025 Women of Influence.

TEL AVIV, Israel, July 03, 2025 (GLOBE NEWSWIRE) -- REE Automotive Ltd. (“REE” or the “Company”) (Nasdaq: REE), an automotive technology company that develops software-defined vehicle (SDV) technology solutions, today reported that the Company received a letter (the “Letter”) from the Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company is currently not in compliance with Nasdaq Rule 5450(a)(1). In particular, the Letter stated that the Company’s closing bid price for its Class A ordinary shares (the “Ordinary Shares”) has been below $1.00 per share for the last 30 consecutive business days beginning on May 15, 2025 through June 27, 2025.

DALLAS, July 03, 2025 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA) (Taysha or the Company), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene therapies for severe monogenic diseases of the central nervous system (CNS), today announced that, on July 1, 2025, the Compensation Committee of Taysha's Board of Directors granted two new employees, in the aggregate, options to purchase 30,000 shares of the Company's common stock in connection with their employment. The stock options were granted under the Taysha Gene Therapies, Inc. 2023 Inducement Plan as an inducement material to the individuals entering employment with Taysha in accordance with Nasdaq Listing Rule 5635(c)(4).